Mirati Seeks Differentiation, Amgen Invests In Combos To Dominate KRAS G12C Field

Biomarker Data Confirm Amgen Strategy; Mirati’s Drug Works In CNS

 
• By Mandy Jackson
Business competition concept with Colorful paper ships on white background
Amgen was first to market but Mirati is close behind • Source: Shutterstock

More from ASCO

More from Conferences